Matches in Wikidata for { <http://www.wikidata.org/entity/Q65540694> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q65540694 description "clinical trial" @default.
- Q65540694 description "ensayu clínicu" @default.
- Q65540694 description "klinisch onderzoek" @default.
- Q65540694 description "клінічне випробування" @default.
- Q65540694 description "կլինիկական փորձարկում" @default.
- Q65540694 name "Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer" @default.
- Q65540694 name "Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer" @default.
- Q65540694 type Item @default.
- Q65540694 label "Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer" @default.
- Q65540694 label "Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer" @default.
- Q65540694 prefLabel "Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer" @default.
- Q65540694 prefLabel "Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer" @default.
- Q65540694 P1132 Q65540694-12366702-D2B3-41D3-B245-8FD01530FBC3 @default.
- Q65540694 P1476 Q65540694-35F9EAA7-6F0D-4509-BE07-AC8F6303BE65 @default.
- Q65540694 P17 Q65540694-1E0EE5A7-C003-4400-AB3B-4047343D4B07 @default.
- Q65540694 P17 Q65540694-AB6B487D-8F69-4A88-A290-875C853AF2F7 @default.
- Q65540694 P17 Q65540694-F433A233-99E9-46E2-B429-F83FEB2E12BE @default.
- Q65540694 P2899 Q65540694-73480289-9E28-4C02-86A8-F3C3F44E1E2F @default.
- Q65540694 P3098 Q65540694-3EC62D66-6EE4-437F-B69A-70F3DECB4938 @default.
- Q65540694 P31 Q65540694-BE7A0F3E-662A-48A3-BFC2-4010DDA5CDAB @default.
- Q65540694 P4844 Q65540694-166667AE-69E9-4F77-AFAD-1FD4FB65D6D5 @default.
- Q65540694 P580 Q65540694-11BB5069-A28C-416F-9EB8-7987340E7357 @default.
- Q65540694 P582 Q65540694-1C6FFB47-DE69-4E63-8E9D-B6FC2B474850 @default.
- Q65540694 P6099 Q65540694-B665FF2F-B2D2-4346-8C6A-977E292B2ED6 @default.
- Q65540694 P6153 Q65540694-14C95649-324D-48FA-9C28-F0FF74D4199B @default.
- Q65540694 P6153 Q65540694-2DF31DBF-11A9-49F6-ABD3-9D4E57402857 @default.
- Q65540694 P6153 Q65540694-4E383420-79B1-4B3C-BBEF-BA8ED289B467 @default.
- Q65540694 P6153 Q65540694-61143FE6-A7CB-4F56-875C-4FEEDCF977F9 @default.
- Q65540694 P6153 Q65540694-68616816-FD31-4395-B6A3-C4F571F3343D @default.
- Q65540694 P6153 Q65540694-76BE7CC0-B2CD-4A80-9B05-592FD7E78871 @default.
- Q65540694 P6153 Q65540694-DE440AF4-FADF-49DA-BE3E-479C0DE54337 @default.
- Q65540694 P8363 Q65540694-398C9B67-F722-4A33-B15B-60977F1F99A4 @default.
- Q65540694 P1132 "+360" @default.
- Q65540694 P1476 "A Phase III Trial Comparing Docetaxel Every Third Week to Biweekly Docetaxel Monotherapy in Metastatic Hormone Refractory Prostate Cancer Patients - PROSTY Trial" @default.
- Q65540694 P17 Q27 @default.
- Q65540694 P17 Q33 @default.
- Q65540694 P17 Q34 @default.
- Q65540694 P2899 "+18" @default.
- Q65540694 P3098 "NCT00255606" @default.
- Q65540694 P31 Q30612 @default.
- Q65540694 P4844 Q424972 @default.
- Q65540694 P580 "2005-08-01T00:00:00Z" @default.
- Q65540694 P582 "2009-05-01T00:00:00Z" @default.
- Q65540694 P6099 Q42824827 @default.
- Q65540694 P6153 Q10662008 @default.
- Q65540694 P6153 Q28695 @default.
- Q65540694 P6153 Q30279684 @default.
- Q65540694 P6153 Q38251273 @default.
- Q65540694 P6153 Q56403399 @default.
- Q65540694 P6153 Q6786523 @default.
- Q65540694 P6153 Q7855557 @default.
- Q65540694 P8363 Q78089383 @default.